Dossier Hub

drug

Open full archive

Curated coverage for drug with top developments, timeline context, and connected threads.

Lead CoverageScience06/04/2026, 17:18:01

Gene Editing Could Replace Daily Cholesterol Pills — The Medical Breakthrough Nobody Is Talking About

Getting patients to take daily cholesterol-lowering drugs is one of medicine's biggest challenges. Gene editing could solve it with a single treatment. Here is the science, the trials, and what comes next.

Bulk Importer | Linked source

Dossier Timeline

17 updates
Science02/04/2026, 15:47:16

Why Your Brain Is Better After Exercise — The Neuroscience Nobody Taught You

Aerobic exercise produces more BDNF than any drug available. Here is the specific neuroscience of exercise's brain benefits and the optimal protocol for cognitive function.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:47:07

The Real Reason Why Most People Who Lose Weight Gain It Back

90% of people who lose significant weight regain it within 5 years. New research reveals the specific biological mechanisms that make this almost inevitable — and what GLP-1 drugs do differently.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:47:02

How the Longevity Drugs That Work in Animals Are Failing in Human Trials

Dozens of compounds extend lifespan in mice. Almost none have worked in human trials. Here is the biology behind the translation gap and the researchers who think they know how to cross it.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:46:57

The New Class of Alzheimer's Drug Is Finally Working — Here Is What 'Working' Actually Means

Lecanemab and donanemab slow Alzheimer's progression. Here is the specific clinical benefit, the serious side effects, and the brutal economics of treating the world's most feared disease.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:46:55

The New Science of Gut Bacteria That Eat Your Medication

Gut bacteria can metabolise and inactivate your medications before they reach the bloodstream. New research shows this varies enormously between people and explains why drugs work differently for different people.

EuroBulletin24 Editorial Desk | Linked source

Economy02/04/2026, 15:46:21

The Protein Rush: Why Every Food Company Is Racing to Put More Protein in Your Food

Protein-enriched products are flooding the market as GLP-1 drug users and longevity-focused consumers drive demand. Here is the science behind protein's growing status and who is profiting.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:46:13

The New Pain Drug That Doesn't Require a Needle Is Changing Chronic Pain Treatment

A new class of oral non-opioid pain drugs is in late-stage trials. Here is the mechanism, the clinical results, and when they might reach patients who have exhausted current options.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:46:11

GLP-1 Drugs Are Helping People Stop Drinking — The Addiction Science Nobody Expected

Patients on Ozempic and similar drugs are spontaneously reporting reduced alcohol cravings and consumption. Here is the neuroscience behind why weight-loss drugs might treat addiction.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:46:04

Cell-Free Biomanufacturing Is About to Revolutionise How We Make Medicine

Cell-free protein production platforms can make vaccines and drugs without living organisms. Here is what this breakthrough means for vaccine manufacturing speed and cost.

EuroBulletin24 Editorial Desk | Linked source

Economy02/04/2026, 15:45:58

The GLP-1 Drugs Are Making People Eat Less of Everything — What Food Companies Are Doing About It

Ozempic users eat significantly less. With millions on GLP-1 drugs, food companies are reformulating products for smaller servings. Here is the specific business transformation happening.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:45:56

The New Anti-Pain Drug That Doesn't Cause Addiction Is Changing Everything

Suzetrigine (Journavax) was FDA-approved in January 2025 and is now reshaping pain management. Here is what it is, how it works differently from opioids, and who it could help.

EuroBulletin24 Editorial Desk | Linked source

Science02/04/2026, 15:45:50

The Drug That Was Supposed to Kill Diabetes Just Got Approved for Something Nobody Expected

GLP-1 drugs like Ozempic won FDA approvals for addiction, kidney disease, and heart failure in 2026. Here is the full science behind what these drugs are actually doing to the human body.

EuroBulletin24 Editorial Desk | Linked source

Economy02/04/2026, 10:06:36

The Pharmaceutical Cold War: India Is Europe's Drug Supply Lifeline — And It's Vulnerable

Europe gets 70-80% of its generic medicine from India. The US pharmaceutical tariff threat and India's own policy changes are creating supply chain risks that European health ministries are quietly worried about.

EuroBulletin24 Editorial Desk | Linked source

Economy02/04/2026, 10:06:28

The Pharmaceutical Sector Is Terrified of Trump's 200% Drug Tariff — Here Is Why the Math Doesn't Work

A 200% pharmaceutical tariff would be economically catastrophic for American patients. Here is exactly why the supply chain cannot be reshored quickly enough to prevent it.

EuroBulletin24 Editorial Desk | Linked source

Technology01/04/2026, 17:19:27

AI in Medicine Is No Longer Just Diagnosis — It's Designing Molecules That Have Never Existed

AI systems are now designing entirely new drug molecules that chemists have never imagined. Here is the state of AI-powered drug discovery and what it means for medicine.

EuroBulletin24 Editorial Desk | Linked source

Science01/04/2026, 17:07:19

DNA Robots Are Coming and They Could Deliver Drugs, Fight Viruses, and Build Things Atom by Atom

Scientists are building robots from DNA that can navigate living cells, deliver drugs, and destroy viruses. Here is the state of the technology and how close it is to clinical application.

EuroBulletin24 Editorial Desk | Linked source

Science01/04/2026, 17:07:15

Metformin Works Through the Brain, Not Just the Body — 60 Years After Discovery, Here Is What Was Hidden

Scientists reveal metformin's blood sugar control actually works partly through the brain, not just the liver and muscles. This changes everything about how we understand the world's most prescribed diabetes drug.

EuroBulletin24 Editorial Desk | Linked source